[Myelodysplastic syndromes and autoimmunity].

Area of Science:

• Hematology
• Immunology
• Oncology

Context:

• Myelodysplastic syndromes (MDS) involve ineffective blood cell production from clonal stem cell disorders.
• MDS patients exhibit a higher incidence of systemic inflammatory and autoimmune diseases.
• Autoimmune disease patients face an elevated risk of developing MDS.

Purpose:

• To review the association between myelodysplasia and autoimmunity.
• To provide clinical guidance on identifying MDS in autoimmune patients.
• To list autoimmune conditions that can complicate MDS progression.

Summary:

• MDS, a group of clonal hematopoietic stem cell disorders, leads to inefficient hematopoiesis and peripheral cytopenias.
• A significant link exists between MDS and autoimmune disorders, supported by cohort studies and case reports.
• The relationship is bidirectional: MDS patients are prone to autoimmune diseases, and autoimmune patients have a higher risk of MDS.

Impact:

• Enhances understanding of the complex interplay between MDS and autoimmunity.
• Offers practical insights for clinicians managing patients with either condition.
• Aids in the early detection and management of MDS in the context of autoimmune diseases.